Two existing drugs prevent COVID-19 in human cells: Study
PTI, Aug 18, 2020, 1:37 PM IST
Boston: Two existing drugs inhibit SARS-CoV-2, the virus that causes COVID-19, from infecting human cells in the lab, a study has found.
According to the study, published in the journal PNAS, both drugs, vacuolin-1, and apilimod, originally developed years ago, target a large enzyme called PIKfyve kinase.
“Before this study, little was known about this enzyme”s role in COVID-19 infection,” the researchers said.
“The work, which will need to be replicated in human trials, suggests a potential new target for COVID-19 therapies,” they said.
“Our findings show that targeting this kinase through a small-molecule antiviral against SARS-CoV-2 may be an effective strategy to lessen the progression or seriousness of COVID-19,” said study co-senior author Tomas Kirchhausen, a professor at the Harvard Medical School (HMS) in the US.
Kirchhausen said that he discovered vacuolin-1 16 years ago, while apilimod was developed by a company called LAM Therapeutics.
Kirchhausen performed cell biology studies with the SARS-CoV-2 virus in the lab of Sean Whelan, who had been part of the Center for Excellence team at HMS.
“Within a week, we knew apilimod worked extremely well in preventing SARS-CoV-2 infection in human cells in the lab,” said Kirchhausen, who initially published this discovery on the bioRxiv pre-print website in April 2020.
That pre-print also included a review of apilimod”s effectiveness against Ebola and SARS-CoV-2.
“We found that like apilimod, vacuolin-1 is a very strong inhibitor for viral infection in the lab,” said Kirchhausen.
The HMS researchers noted that an unrelated group has published a paper in the journal Nature, showing that, in a screen of 12,000 clinical-stage or FDA-approved small molecules, apilimod was one of the best drugs for inhibiting SARS-CoV-2 virus replication.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Don’t blame Dubai’s freak rain on cloud seeding
ISRO Gears Up to Test Critical Parachute Safety of Gaganyaan
Indian students bag NASA awards for Human Exploration Rover Challenge
‘Mastering the Data Paradox’: Book uncovers pivotal role of data in AI age
Bitcoin’s latest ‘halving’ has arrived. Here’s what you need to know
MUST WATCH
Latest Additions
Kollegela MLA A.R. Krishnamurthy escapes unhurt in car mishap
Lok Sabha elections 2024: EC takes cognisance of MCC violation by Modi, Rahul; seeks response by April 29
Polali: Case filed against a man for molesting minor
Kotak Mahindra Bank shares tank 13%; mcap erodes by Rs 37,721 crore post RBI action
Lok Sabha polls 2024: Sunita Kejriwal likely to join AAP’s campaign in Delhi, will hold roadshows this weekend